BioTelemetry (NASDAQ: BEAT) disclosed the following with its 10-Q, which was filed Friday morning [emphasis ours]:As part of our business ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE